1 Min Read
Jan 9(Reuters) - Shenzhen Neptunus Bioengineering Co Ltd
* Says it received approval for conducting phase II trials for polydatin injection in the U.S.
Source text in Chinese: goo.gl/ben7y1
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.